CNTO 2476
Sponsors
Centocor, Inc., Janssen Research & Development, LLC
Conditions
Age-related Macular DegenerationRetinitis Pigmentosa
Phase 1
A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
TerminatedNCT00458575
Start: 2007-04-30End: 2013-08-31Updated: 2014-06-26
A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration
CompletedNCT01226628
Start: 2010-10-21End: 2017-05-31Updated: 2017-08-08